Kathryn J. Potter

1.5k total citations
42 papers, 1.2k citations indexed

About

Kathryn J. Potter is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kathryn J. Potter has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 14 papers in Pulmonary and Respiratory Medicine and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kathryn J. Potter's work include Cystic Fibrosis Research Advances (14 papers), Pancreatic function and diabetes (13 papers) and Diabetes Management and Research (11 papers). Kathryn J. Potter is often cited by papers focused on Cystic Fibrosis Research Advances (14 papers), Pancreatic function and diabetes (13 papers) and Diabetes Management and Research (11 papers). Kathryn J. Potter collaborates with scholars based in Canada, United States and France. Kathryn J. Potter's co-authors include C. Bruce Verchere, Daniel P. Raleigh, Clara Westwell‐Roper, Agnieszka Klimek‐Abercrombie, Garth L. Warnock, Paul E. Fraser, Peter Marek, Galina Soukhatcheva, Jan A. Ehses and Derek L. Dai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Molecular Biology.

In The Last Decade

Kathryn J. Potter

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathryn J. Potter Canada	16	594	418	383	350	259	42	1.2k
Kari T. Chambers United States	21	495 0.8×	434 1.0×	594 1.6×	162 0.5×	228 0.9×	27	1.4k
Emma Assi Italy	16	147 0.2×	127 0.3×	352 0.9×	86 0.2×	254 1.0×	25	873
Xiemin Cao Canada	19	860 1.4×	313 0.7×	722 1.9×	171 0.5×	1.4k 5.2×	24	2.0k
Chris Hillier United Kingdom	17	177 0.3×	244 0.6×	346 0.9×	49 0.1×	251 1.0×	48	1.1k
Birgitte Ursø Denmark	20	219 0.4×	342 0.8×	769 2.0×	88 0.3×	282 1.1×	25	1.6k
Samuel T. Nadler United States	11	191 0.3×	383 0.9×	477 1.2×	187 0.5×	84 0.3×	17	1.1k
Jan O. Johansson United States	20	274 0.5×	271 0.6×	632 1.7×	58 0.2×	159 0.6×	51	1.3k
Verónica Sancho Spain	20	325 0.5×	199 0.5×	472 1.2×	34 0.1×	313 1.2×	34	1.0k
Tomomi Matsuura Japan	18	240 0.4×	125 0.3×	805 2.1×	36 0.1×	111 0.4×	56	1.4k
Anaïs Brassier France	19	194 0.3×	714 1.7×	608 1.6×	157 0.4×	269 1.0×	84	1.7k

Countries citing papers authored by Kathryn J. Potter

Since Specialization

Citations

This map shows the geographic impact of Kathryn J. Potter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn J. Potter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn J. Potter more than expected).

Fields of papers citing papers by Kathryn J. Potter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn J. Potter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn J. Potter. The network helps show where Kathryn J. Potter may publish in the future.

Co-authorship network of co-authors of Kathryn J. Potter

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn J. Potter. A scholar is included among the top collaborators of Kathryn J. Potter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn J. Potter. Kathryn J. Potter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Potter, Kathryn J., et al.. (2025). Effects of GLP-1 receptor agonist therapy on resolution of steatohepatitis in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Journal of the Canadian Association of Gastroenterology. 8(2). 47–57. 1 indexed citations

Potter, Kathryn J., Adèle Coriati, François Tremblay, et al.. (2024). Cystic fibrosis‐related diabetes develops from a combination of insulin secretion defects and insulin resistance. Diabetes Obesity and Metabolism. 26(10). 4744–4752. 1 indexed citations

Potter, Kathryn J., Adèle Coriati, Larry C. Lands, et al.. (2023). Canadian Cystic Fibrosis–related Diabetes Clinical Practice Survey: Analysis of Current Practices and Gaps in Clinical Care. Canadian Journal of Diabetes. 47(3). 263–271.e1. 5 indexed citations

Potter, Kathryn J., Valérie Boudreau, Julie Lacombe, et al.. (2023). Low vitamin K status in adults with cystic fibrosis is associated with reduced body mass index, insulin secretion, and increased pseudomonal colonization. Applied Physiology Nutrition and Metabolism. 48(4). 321–330. 3 indexed citations

Tagougui, Sémah, Laurent Legault, Elsa Heyman, et al.. (2022). Anticipated Basal Insulin Reduction to Prevent Exercise-Induced Hypoglycemia in Adults and Adolescents Living with Type 1 Diabetes. Diabetes Technology & Therapeutics. 24(5). 307–315. 6 indexed citations

Chen, Yi‐Chun, Agnieszka Klimek‐Abercrombie, Kathryn J. Potter, et al.. (2022). Elevated islet prohormone ratios as indicators of insulin dependency in auto-islet transplant recipients. American Journal of Transplantation. 22(8). 1992–2005. 7 indexed citations

Potter, Kathryn J., Valérie Boudreau, François Tremblay, et al.. (2022). Insulinogenic index and early phase insulin secretion predict increased risk of worsening glucose tolerance and of cystic fibrosis-related diabetes. Journal of Cystic Fibrosis. 22(1). 50–58. 11 indexed citations

Potter, Kathryn J., Valérie Boudreau, François Tremblay, et al.. (2022). Marginal association of fasting blood glucose with the risk of cystic fibrosis-related diabetes. Annales d Endocrinologie. 84(2). 265–271. 3 indexed citations

Prentice, Bernadette, Kathryn J. Potter, Adèle Coriati, et al.. (2022). Cystic Fibrosis-Related Diabetes: Clinical approach and knowledge gaps. Paediatric Respiratory Reviews. 46. 3–11. 10 indexed citations

10.

Potter, Kathryn J., Quitterie Reynaud, Valérie Boudreau, et al.. (2021). Prevalence of Post–Glucose Challenge Hypoglycemia in Adult Patients With Cystic Fibrosis and Relevance to the Risk of Cystic Fibrosis–Related Diabetes. Canadian Journal of Diabetes. 46(3). 294–301.e2. 1 indexed citations

11.

Potter, Kathryn J., Valérie Boudreau, Katherine Desjardins, et al.. (2021). Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis. Diabetologia. 64(6). 1332–1341. 18 indexed citations

12.

Potter, Kathryn J., Valérie Boudreau, François Tremblay, et al.. (2021). Insulinogenic Index and Early Phase Insulin Secretion Predict Increased Risk of Worsening Glucose Tolerance and of Cystic Fibrosis-Related Diabetes. Canadian Journal of Diabetes. 45(7). S33–S33. 1 indexed citations

13.

Potter, Kathryn J., Valérie Boudreau, Azadeh Shohoudi, et al.. (2021). Influence of pre-diabetic and pancreatic exocrine states on pulmonary and nutritional status in adults with Cystic Fibrosis. Journal of Cystic Fibrosis. 20(5). 803–809. 18 indexed citations

14.

Rabasa‐Lhoret, Rémi, et al.. (2020). Dyslipidemia is not associated with the development of glucose intolerance or diabetes in cystic fibrosis. Journal of Cystic Fibrosis. 19(5). 704–711. 9 indexed citations

15.

Potter, Kathryn J., Heather C. Denroche, Joel Montané, et al.. (2015). Amyloid Formation in Human Islets Is Enhanced by Heparin and Inhibited by Heparinase. American Journal of Transplantation. 15(6). 1519–1530. 28 indexed citations

16.

Gidrewicz, Dominica, Kathryn J. Potter, Cynthia Trevenen, Martha E. Lyon, & Decker Butzner. (2015). Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population. The American Journal of Gastroenterology. 110(5). 760–767. 53 indexed citations

17.

Bailey, James, Kathryn J. Potter, C. Bruce Verchere, Leah Edelstein‐Keshet, & Daniel Coombs. (2011). Reverse engineering an amyloid aggregation pathway with dimensional analysis and scaling. Physical Biology. 8(6). 66009–66009. 10 indexed citations

18.

Meng, Fanling, Andisheh Abedini, Annette Plesner, et al.. (2010). The Sulfated Triphenyl Methane Derivative Acid Fuchsin Is a Potent Inhibitor of Amyloid Formation by Human Islet Amyloid Polypeptide and Protects against the Toxic Effects of Amyloid Formation. Journal of Molecular Biology. 400(3). 555–566. 42 indexed citations

19.

Meng, Fanling, Peter Marek, Kathryn J. Potter, C. Bruce Verchere, & Daniel P. Raleigh. (2008). Rifampicin Does Not Prevent Amyloid Fibril Formation by Human Islet Amyloid Polypeptide but Does Inhibit Fibril Thioflavin-T Interactions: Implications for Mechanistic Studies of β-Cell Death. Biochemistry. 47(22). 6016–6024. 87 indexed citations

20.

Jones, I. Chester, IG Jarrett, G. P. Vinson, & Kathryn J. Potter. (1964). ADRENOCORTICOSTEROID PRODUCTION OF FOETAL SHEEP NEAR TERM. Journal of Endocrinology. 29(2). 211–212. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact